- Home
- ADEA vs PRGO Comparison
ADEA vs PRGO Comparison
Compare ADEA & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADEA | PRGO |
|---|---|---|
| Founded | 1990 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ADEA | PRGO |
|---|---|---|
| Price | $19.86 | $10.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $26.50 | $19.33 |
| AVG Volume (30 Days) | 873.1K | ★ 2.8M |
| Earning Date | 05-26-2026 | 05-29-2026 |
| Dividend Yield | 0.95% | ★ 10.36% |
| EPS Growth | ★ 73.68 | N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $443,386,000.00 | $800,000.00 |
| Revenue This Year | N/A | $0.02 |
| Revenue Next Year | $7.90 | $1.36 |
| P/E Ratio | $21.18 | ★ N/A |
| Revenue Growth | ★ 17.91 | N/A |
| 52 Week Low | $10.59 | $11.13 |
| 52 Week High | $21.07 | $29.08 |
Technical Indicators
Market Signals| Indicator | ADEA | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 22.11 |
| Support Level | $16.21 | N/A |
| Resistance Level | $19.97 | $15.08 |
| Average True Range (ATR) | 0.90 | 0.60 |
| MACD | 0.05 | -0.41 |
| Stochastic Oscillator | 67.82 | 2.84 |
Price Performance
Historical ComparisonAbout ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. It's the only operating segment, being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.